Misonix designs, develops, manufactures, and markets medical, scientific,
and industrial ultrasonic equipment, laboratory safety equipment, and air
pollution control products.
Misonix's ultrasonic platform is the basis for several innovative medical
technologies. Misonix has a minority equity position in Focus Surgery, Inc.
which uses high intensity focused ultrasound technology to destroy
deep-seated cancerous tissues without affecting surrounding healthy tissue.
Addressing a combined market estimated to be in excess of $4 billion
annually, Misonix's proprietary ultrasonic medical devices are used for
wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and
other surgical and medical applications.